Laboratorios Farmaceuticos Rovi, S.A. Share Price Wiener Boerse
Stocks
ROVI
ES0157261019
Pharmaceuticals
OTC Markets Traded|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 56.80 EUR | -1.30% |
|
-1.22% | -10.27% |
| 13/05 | Spanish stocks - Factors to watch on May 13 | RE |
| 09/05 | Laboratorios Farmaceuticos Rovi, S.A., Q1 2026 Earnings Call, May 06, 2026 |
| Market Cap | 287.2Cr 328.31Cr 264.85Cr 245.05Cr 465.12Cr 31TCr 472.9Cr 3.17TCr 1.24TCr 15TCr 1.23TCr 1.21TCr 53TCr | P/E 2026 * |
21.5x | P/E 2027 * | 16.2x |
|---|---|---|---|---|---|
| Enterprise Value | 284.42Cr 325.12Cr 262.28Cr 242.67Cr 460.61Cr 31TCr 468.31Cr 3.14TCr 1.23TCr 15TCr 1.22TCr 1.19TCr 53TCr | EV / Sales 2026 * |
3.67x | EV / Sales 2027 * | 3.1x |
| Free-Float |
31.63% | Yield 2026 * |
1.73% | Yield 2027 * | 1.99% |
Last Transcript: Laboratorios Farmaceuticos Rovi, S.A.
| 1 day | -1.30% | ||
| 1 week | -1.22% | ||
| Current month | -1.90% | ||
| 1 month | -3.57% | ||
| 3 months | -31.48% | ||
| 6 months | -16.78% | ||
| Current year | -10.27% |
| 1 week | 56.2 |  | 57.65 |
| 1 month | 56.2 | | 59.6 |
| Current year | 56.2 | | 86.6 |
| 1 year | 51.85 | | 86.6 |
| 3 years | 38.38 | | 90.75 |
| 5 years | 35.64 | | 90.75 |
| 10 years | 35.64 | | 90.75 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | 27/07/2007 | |
| Director of Finance/CFO | - | 01/01/2001 | |
| Chief Tech/Sci/R&D Officer | - | 01/01/2014 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | - | 17/07/2021 | |
| Director/Board Member | - | 27/07/2007 | |
| Director/Board Member | - | 27/07/2007 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.30% | -1.22% | - | - | 327.16Cr | |
| +0.09% | +2.12% | +56.49% | +169.19% | 1,08400Cr | |
| -1.63% | +2.02% | +66.31% | +62.70% | 63TCr | |
| -1.12% | -0.46% | +31.69% | +84.44% | 45TCr | |
| +0.18% | +2.04% | +30.19% | +26.51% | 33TCr | |
| -6.22% | -3.61% | +29.15% | +32.09% | 30TCr | |
| -1.27% | -0.56% | +27.21% | +46.39% | 28TCr | |
| -0.93% | -1.19% | -28.85% | -40.38% | 22TCr | |
| -1.19% | +0.63% | +22.43% | +66.30% | 20TCr | |
| -0.72% | +7.04% | +21.41% | +81.19% | 17TCr | |
| Average | -1.28% | +2.52% | +28.45% | +58.71% | 40.67TCr | |
| Weighted average by Cap. | -0.90% | +2.48% | +39.76% | +84.80% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 77Cr 88Cr 71Cr 66Cr 125.35Cr 8.45TCr 127.45Cr 854.8Cr 335.08Cr 4.15TCr 332.16Cr 324.98Cr 14TCr | 90Cr 102.67Cr 83Cr 77Cr 145.46Cr 9.8TCr 147.89Cr 991.94Cr 388.84Cr 4.81TCr 385.45Cr 377.11Cr 17TCr |
| Net income | 13Cr 15Cr 12Cr 11Cr 22Cr 1.45TCr 22Cr 146.86Cr 58Cr 712.55Cr 57Cr 56Cr 2.47TCr | 18Cr 20Cr 16Cr 15Cr 29Cr 1.94TCr 29Cr 196.14Cr 77Cr 951.63Cr 76Cr 75Cr 3.3TCr |
| Net Debt | -2.79Cr -3.19Cr -2.57Cr -2.38Cr -4.51Cr -304.12Cr -4.59Cr -31Cr -12Cr -149.34Cr -12Cr -12Cr -517.3Cr | -8.59Cr -9.82Cr -7.92Cr -7.33Cr -14Cr -937.26Cr -14Cr -95Cr -37Cr -460.25Cr -37Cr -36Cr -1.59TCr |
| Date | Price | Change |
|---|---|---|
| 09/26/09 | €56.25 | +0.09% |
| 08/26/08 | €56.20 | -1.75% |
| 07/26/07 | €57.20 | 0.00% |
| 06/26/06 | €57.20 | +0.70% |
| 03/26/03 | €56.80 | -1.30% |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ROVI Stock
- ROVI Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
